作者: Ahamad Malkawi , Abeer M. Al-Ghananeem
DOI:
关键词:
摘要: This application relates to a stable liquid aqueous formulations comprising at least about 10 mg/ml of apomorphine hydrochloride hemihydrate (apomorphine HQ), which are substantially free antioxidant agents, such as sodium metabisulfite. formulation is designed improve patient tolerance and compliance, while the same time maintaining stability pharmaceutical formulation. These may be used in treatment and/or management advanced cases Parkinson's disease.